Inventiva (IVEVF) Income from Non-Controlling Interests (2022)
Inventiva (IVEVF) posted Income from Non-Controlling Interests of -$13263.2 for Q4 2022.
Powered by 
Analysis
Inventiva (IVEVF) Income from Non-Controlling Interests (2022) Analysis & Trends
Inventiva has reported Income from Non-Controlling Interests for 1 years, with the latest figure at -$13263.2 in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.70 Bn | 621.95 Bn | 17.26 Bn | - |
| 2 | AbbVie | 440.80 Bn | 434.23 Bn | 12.70 Bn | 3.00 Mn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -2.00 Mn |
| 4 | Novartis Ag | 266.37 Bn | 258.68 Bn | 11.24 Bn | -7.00 Mn |
| 5 | Pfizer | 158.89 Bn | 147.19 Bn | 10.94 Bn | 10.00 Mn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 39.52 Mn |
| 7 | Revolution Medicines | 44.38 Bn | 44.38 Bn | - | - |
| 8 | Incyte | 25.28 Bn | 20.74 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn | - |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - | - |